Related Experiment Videos

Vaccine risk and benefit in the developing world

Jerald C Sadoff

Health Affairs (Project Hope)

|September 16, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.

American journal of respiratory and critical care medicine·2017

A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungs.

Human vaccines & immunotherapeutics·2014

The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses.

Vaccine·2014

Aerosol vaccination with AERAS-402 elicits robust cellular immune responses in the lungs of rhesus macaques but fails to protect against high-dose Mycobacterium tuberculosis challenge.

Journal of immunology (Baltimore, Md. : 1950)·2014

Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.

American journal of respiratory and critical care medicine·2013

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.

Nature·2012

See all related articles